Eastern Deanery Aids Relief Program (EDARP) is a faith based program under the Roman Catholic Church. Eastern Deanery AIDS Relief Program was founded in 1993 to respond to the numerous incidences of HIV infection which affected the communities living in the eastern side of the city of Nairobi. The number of HIV/AIDS related deaths at the time were numerous as many people were not aware of HIV and antiretroviral drugs were also not available. Father Edward Phillips M.M. who was a priest under Maryknoll Fathers and Brothers congregation and was working in Eastland’s Nairobi with the Archdiocese of Nairobi during the time developed a HIV/AIDS intervention program to address this problem. During the inception of EDARP the program was funded by the Maryknoll Fathers & Brothers and Misereor, a German Roman Catholic development agency.
EDARP activities have since expanded to HIV/TB prevention, Counseling, Testing and Treatment services. All services offered in EDARP facilities are FREE. EDARP facilities are located within the following areas within Eastland’s Nairobi;
Shauri Moyo, Eastleigh, Mathare, Huruma, Baba Dogo, Kariobangi, Dandora, Ruai, Njiru, Komarock, Soweto, Donholm, St. Veronica Eastleigh 1st Avenue and Dandora Phase 5.
EDARP’s mission is to provide Holistic TB/HIV Prevention, Care and Treatment to all affected and infected people living in Eastern slums of Nairobi, Regardless of their Age, Creed, Gender, Ethnicity or Nationality.
To reduce the burden of TB/HIV in the Eastern slums of Nairobi through Innovative Prevention, Care and Treatment Strategies in a Community Based Approach.
TB is caused by the bacterium Mycobacterium tuberculosis. TB usually affects the lungs, known as pulmonary TB, but may affect almost any other part of the body, known as extra-pulmonary TB.
WHAT ARE THE SYMPTOMS OF TB?
The most common symptom of Tb is a persistent, productive cough usually for more than 2 weeks. Other constitutional symptoms include persistent fever, unexplained weight loss, night sweats, anorexia (loss of appetite) and fatigue.
Other respiratory symptoms may include shortness of breath, chest and back pain and haemoptysis. Symptoms of extrapulmonary TB are related to specific extrapulmonary sites such as lymph nodes, pleura, larynx, meninges, genito-urinary, intestinal tract, bone, spinal cord and skin.
|Thursday, 26 September 2013 08:00||St. Jude Catholic Church Donholm, Nairobi||Celebrating 20 years of innovative community health care... Read More...||Celebrating 20 years of innovative community health care||EDARP|
|Saturday, 23 August 2014 08:00||Donholm Main Office||EDARP scientific conference is an annual event whose aim is to strength and capacity build all EDARP employees skills in... Read More...||Scientific Conference||EDARP|
The incidence of new cases worldwide is falling too slowly at around 1 percent per year. Multidrug-resistant TB is on the increase, particularly in Eastern Europe and parts of Asia. Levels of case detection and successful treatment are far too low. Only 12 percent (30,000) of the estimated cases were notified in 2009 and less than 5 percent were properly treated. The Global Fund is the major donor for responses to multidrug-resistant TB. Programs it supports treated 14,000 cases in 2009, equivalent to nearly 60 percent of the 23,000 enrolled for treatment globally that year, and an additional 13,000 in 2010 – bringing the total treated with Global Fund support to 43,000 at December 2010.
The HIV epidemic has fueled the TB epidemic, particularly in sub-Saharan Africa. Too little is done to prevent TB among people living with HIV, who account for 13 percent of the new TB cases in 2009. Less than 1 percent of the estimated number of people living with HIV worldwide received isoniazid preventive therapy in 2009 and only 26 percent of TB patients knew their HIV status. Service coverage for TB/HIV co-infections remains very low. By December 2010 Global Fund-supported programs had provided a total of 2.4 million TB/HIV services.
* As of 2010, WHO has discontinued the 70 percent target for case detection since there is major uncertainty about its true value in most countries.